Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin for prevention of radiation-induced skin toxicity in breast cancer
ACTRN12612000662864Phase 2Completed
- Sponsor
- Waikato District Health Board
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in breast cancer comparing Simvastatin with Placebo/control (2 arms). Primary endpoint: Incidence of grade 2 or greater acute radiation-related skin toxicity. Started Jan 2013; status: completed.
02
Drugs
simvastatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on ACTRN12612000662864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000662864.